Join the club for FREE to access the whole archive and other member benefits.

M3DIMAKER 3D printer for personalized medicine, launched

Revolutionary tech to tailor patient-specific drugs for research and actual use

10-Apr-2020

Key points from article :

M3DIMAKER it the world's first pharmaceutical 3D printer for personalized medicines.

Completed world's first in-human clinical study with 3D printed tablets in 2019.

It has been tested around the world in pharmacies, research institutes, and hospitals.

Features multiple nozzles for adaptive manufacturing purposes.

Made with “sleek hardware system” controlled by special user-friendly software.

Can select required dose chosen by a physician’s prescription, prescribed by a pharmacist.

Has built-in camera for error detection, progress tracking, and quality control.

Can make one month’s worth of medication in ~8 minutes, depending on the medication.

It can make pills using both FDM technology and direct powder extrusion.

3D printed tablets can even combine more than one medication into a single polypill.

Ensures security and reliability by using fingerprint access control and data matrix reader.

Technology by FabRx Ltd., a pharma biotech spin-out company from UCL’s School of Pharmacy.

Mentioned in this article:

Click on resource name for more details.

Alvaro Goyanes

Co-Founder and Director of Development - FabRx Ltd.

FabRx

Specialist biotech company developing 3D printing technology for pharmaceuticals and medical devices.

M3DIMAKER

World's first pharmaceutical 3D printer for personalised medicines, FabRx

University College London (UCL)

Diverse global community of world-class academics, students, industry links, external partners, and alumni

Topics mentioned on this page:
3D Printing